We all differ in our response to drug treatment-occasionally with dramatic
effects. The era of "one drug fits all patients" is about to give way to in
dividualised therapy matching the patient's unique genetic make up with an
optimally effective drug.(1) Pharmacogenetics and pharmacogenomics are the
emerging disciplines that ale leading the way towards individualised medici
ne.(2 3) Initially, researchers focused their attention on pharmacogenetics
-variations In single candidate genes responsible for variable drug respons
e. Subsequently, studies involving the entire human genome broadened the sl
ope of investigation, giving rise to pharmacogenomics as one of the "hottes
t" fields in biotechnology today.